渥太华的生物技术中心在78万元联邦支持下扩张, Ottawa’s biotech center expands with $78M federal support, doubling size to boost advanced therapy production.

渥太华医院的生物治疗制造中心正转移到渥太华大学高级医学研究中心,其规模增加了一倍多。 The Ottawa Hospital’s Biotherapeutics Manufacturing Centre is moving to the University of Ottawa’s Advanced Medical Research Centre, more than doubling its size. 在7 800万美元的联邦赠款支持下,这一扩大将提高加拿大的生物制造能力,使诸如MRNA疗法和CAR T细胞疗法等先进疗法的生产成为可能。 Backed by a $78 million federal grant, the expansion will boost Canada’s biomanufacturing capacity, enabling production of advanced therapies like mRNA treatments and CAR T-cell therapies. 该伙伴关系旨在加强生物治疗、临床试验和生物防御方面的国家领导作用,改善获得尖端治疗的机会,在全球卫生和地缘政治变化中支持国内生物技术增长。 The partnership aims to strengthen national leadership in biotherapeutics, clinical trials, and biodefence, improving access to cutting-edge treatments and supporting domestic biotech growth amid global health and geopolitical shifts.